OrthoSensor, Inc.

Zimmer Biomet Holdings, Inc. and its partner Canary Medical announced on 30 August that the US Food and Drug Administration cleared a de novo application for their Persona IQ implant, the first impla

Stryker Corporation is advancing the development of “smart” orthopedic implants with the acquisition of OrthoSensor, Inc. , a privately held developer of sensor-assisted technology, the companies an

Recently launched drug-coated balloons for peripheral artery disease were awarded Medicare new-technology add-on payments by CMS for the coming fiscal year, building on prior positive reimbursement ne

CMS raised concerns with the new-technology add-on payment applications for all six fiscal year 2016 device applicants in the agency’s hospital inpatient proposed rule, including for drug-coated ballo